VC DEALS
LA-based Divergent Technologies, a startup creating digital manufacturing tools, has secured a $230 million Series D led by Hexagon.
VectorY, an Amsterdam-based drug discovery startup, has raised a $138 million Series A co-led by EQT Life Sciences and the Forbion Growth Opportunities Fund.
The Block, a crypto-focused news outlet, has been purchased by Foresight Ventures for $70 million, Financial Times reported.
ViaNautis Bio has raised a $25 million Series A led by 4Bio Capital, BGF and UCB Ventures for its drug delivery system.
Shekel Mobility, an African automotive marketplace startup, has raised $7 million in seed funding led by Ventures Platform and MaC Venture Capital.
Solar marketplace operator Otovo has raised 450 million Norwegian kroner (around €40 million) in a round led by existing investors A Energi, Axel Johnson Group and Nysno.
Filu, a German startup that builds veterinary clinics, has raised €5.1 million co-led by DN Capital and YZR Capital.
UK-based wave energy developer Mocean Energy has raised £2.2 million from existing investors including Equity Gap, Scottish Enterprise and Old College Capital.
LA-based Divergent Technologies, a startup creating digital manufacturing tools, has secured a $230 million Series D led by Hexagon.
VectorY, an Amsterdam-based drug discovery startup, has raised a $138 million Series A co-led by EQT Life Sciences and the Forbion Growth Opportunities Fund.
The Block, a crypto-focused news outlet, has been purchased by Foresight Ventures for $70 million, Financial Times reported.
ViaNautis Bio has raised a $25 million Series A led by 4Bio Capital, BGF and UCB Ventures for its drug delivery system.
Shekel Mobility, an African automotive marketplace startup, has raised $7 million in seed funding led by Ventures Platform and MaC Venture Capital.
Solar marketplace operator Otovo has raised 450 million Norwegian kroner (around €40 million) in a round led by existing investors A Energi, Axel Johnson Group and Nysno.
Filu, a German startup that builds veterinary clinics, has raised €5.1 million co-led by DN Capital and YZR Capital.
UK-based wave energy developer Mocean Energy has raised £2.2 million from existing investors including Equity Gap, Scottish Enterprise and Old College Capital.
Forwarded from 한투증권 미국/중국전략 정정영
* 독일의약품감독관리국, 비만약 수출금지 고려
据新浪财经援引德媒消息，德国药品监管局考虑出台减肥药出口禁令。
据新浪财经援引德媒消息，德国药品监管局考虑出台减肥药出口禁令。
Forwarded from 한국경제 (@The Korea Economic Daily)
[속보] 美 하원, 임시예산안 통과..."셧다운 리스크 우선 해소"
https://www.hankyung.com/article/2023111571715
https://www.hankyung.com/article/2023111571715
한국경제
美 하원, 임시예산안 통과..."셧다운 리스크 우선 해소"
美 하원, 임시예산안 통과..."셧다운 리스크 우선 해소", 뉴스
Forwarded from Market News Feed
BREAKING: BLOOMBERG REPORTS THAT THE UNITED STATES HAS INCREASED AID OF SUPPLYING SHELLS AND MISSILES FOR ISRAELI APACHE GUNSHIPS, ARMY VEHICLES AND BUNKER-BUSTER MUNITIONS. ...
Forwarded from 주식 로켓단
순서대로
1. Ranked: The Most Innovative Countries in 2023 : 한국 10위
2. Ranking the Credit Ratings of Major Economies
: 한국 7위
3. Charted: The Average Cost of Insulin By Country
1. Ranked: The Most Innovative Countries in 2023 : 한국 10위
2. Ranking the Credit Ratings of Major Economies
: 한국 7위
3. Charted: The Average Cost of Insulin By Country
'나무 심어 탄소 감축' 유행시킨 교수 "내가 산업계에 면죄부 줬다"
https://m.hankookilbo.com/News/Read/A2023111416400000120
https://m.hankookilbo.com/News/Read/A2023111416400000120
Forwarded from 한국경제 (@The Korea Economic Daily)
16일부터 퇴직연금 운용 자유도 커진다…'전부 MMF 투자도 가능'
https://www.hankyung.com/article/202311159206i
https://www.hankyung.com/article/202311159206i
한국경제
16일부터 퇴직연금 운용 자유도 커진다…'전부 MMF 투자도 가능'
16일부터 퇴직연금 운용 자유도 커진다…'전부 MMF 투자도 가능', 선한결 기자, 뉴스
Forwarded from 한국경제 (@The Korea Economic Daily)
재닛 옐런 "APEC서 가상자산 규제 논의 계획"
https://www.hankyung.com/article/202311160107B
https://www.hankyung.com/article/202311160107B
한국경제
재닛 옐런 "APEC서 가상자산 규제 논의 계획"
재닛 옐런 "APEC서 가상자산 규제 논의 계획", 뉴스
Forwarded from 인베스트조선 뉴스 채널
SK하이닉스는 줄고 삼성전자는 늘고…재고 변동에서 드러나는 D램 격차
https://www.investchosun.com/site/data/html_dir/2023/11/15/2023111580239.html
https://www.investchosun.com/site/data/html_dir/2023/11/15/2023111580239.html
Investchosun
SK하이닉스는 줄고 삼성전자는 늘고…재고 변동에서 드러나는 D램 격차
바이든·시진핑 회담 종료…바이든 대화 잘 됐다 | 한국경제
https://www.hankyung.com/article/2023111602137
https://www.hankyung.com/article/2023111602137
한국경제
[속보] 바이든·시진핑 회담 종료…바이든 "대화 잘 됐다"
[속보] 바이든·시진핑 회담 종료…바이든 "대화 잘 됐다", 홍민성 기자, 국제
Forwarded from 바이오스펙테이터
노보노디스크가 일라이릴리의 GLP-1/GIP 이중작용제 ‘젭바운드(Zepbound, tirzepatide)’가 비만약으로 출시된지 일주일 만에, 기다렸다는 듯이 곧바로 반격에 나섰습니다. 노보노디스크는 비만 환자 800명을 대상으로 GLP-1 작용제 ‘세마글루타이드(semaglutide, 제품명 위고비)’의 병용요법 ‘카그리세마(CagriSema)’와 젭바운드의 효능을 직접 비교하는 임상3상을 시작했네요.
비만의 강자 노보노디스크와 이를 추격하는 릴리의 불꽃튀는 정면대결이 시작되고 있습니다. 지금까지의 경쟁은 비만 시장에 GLP-1 인크레인(incretin) 약물을 시판하는데 집중돼 있었다면, 이제는 그 다음 챕터로 넘어가면서 업계를 이를 숨죽이고 바라보고 있습니다.
https://m.biospectator.com/view/news_view.php?varAtcId=20346
비만의 강자 노보노디스크와 이를 추격하는 릴리의 불꽃튀는 정면대결이 시작되고 있습니다. 지금까지의 경쟁은 비만 시장에 GLP-1 인크레인(incretin) 약물을 시판하는데 집중돼 있었다면, 이제는 그 다음 챕터로 넘어가면서 업계를 이를 숨죽이고 바라보고 있습니다.
https://m.biospectator.com/view/news_view.php?varAtcId=20346
바이오스펙테이터
노보노 “바로 반격”, ‘위고비 병용vs젭바운드’ 3상 “개시”
노보노디스크(Novo Nordisk)가 일라이릴리(Eli Lilly)의 GLP-1/GIP 이중작용제 ‘젭바운드(Zepbound, tirzepatide)’가 비만약으로 출시된지 1주일 만에
❤1
Walmart: Q3 revenue up 5.2% $160.8 billion
- U.S. Store Revenue Excl. Fuel Up 4.9% (Est. 3.4%)
- Online Revenue Up 15%
- Now Expect Fiscal 2024 EPS $6.40-$6.48, Up From $6.36-$6.46 Prev.
- U.S. Store Revenue Excl. Fuel Up 4.9% (Est. 3.4%)
- Online Revenue Up 15%
- Now Expect Fiscal 2024 EPS $6.40-$6.48, Up From $6.36-$6.46 Prev.